APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753U956. A total of 8 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 100,000 | $3,804,000 | 1.98% |
| GROUP ONE TRADING, L.P. | 429,800 | $16,349,592 | 0.06% |
| SIMPLEX TRADING, LLC | 223,700 | $8,509 | 0.01% |
| SG Americas Securities, LLC | 98,400 | $536 | 0.01% |
| JANE STREET GROUP, LLC | 286,500 | $10,898,460 | 0.00% |
| IMC-Chicago, LLC | 52,600 | $2,000,904 | 0.00% |
| JPMORGAN CHASE & CO | 77,100 | $2,932,884 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
This page lists APELLIS PHARMACEUTICALS INC's shareholders in Q3 2023. To view APELLIS PHARMACEUTICALS INC's shareholder history, click here.